CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance
NCT: NCT05387551 · COMPLETED
Brief Summary
The incidence of type 2 diabetes (T2D) in children is increasing, paralleling the rising incidence of obesity. Preventing children and adolescents from developing T2D is critical. The health benefits of lifestyle modifications are well documented in this population, but success rates are low. Obesity in children and adolescents increases the risk of not only T2D but other complications as well, such as hypertension, dyslipidemias and more. The investigators hypothesize that having real-time glucose data with the use of a continuous glucose monitor (CGM) in obese patients with impaired glucose tolerance will improve adherence to lifestyle modifications. As a result, a decrease in body mass index (BMI) is expected with subsequent improvement in insulin sensitivity, thus reducing risk of obesity-related complications later in childhood/adolescence and adulthood.
Frequently Asked Questions
What is CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance?
CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance is a clinical trial registered under NCT05387551. Current status: COMPLETED.
What is the status of NCT05387551?
The current status of NCT05387551 (CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance) is: COMPLETED.
When did CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance start?
CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance started on 2022-12-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.